Top Markets
Coin of the day
Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCI
Ранг среди акций #37499
Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998,... Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.
Цена акции
$0.05897422
Последняя синхронизация: 2024-04-02
Рыночная капитализация
$1.64M
Изменение (1 день)
0.07%
Изменение (1 год)
-60.68%
Страна
CA
Торговля Intellipharmaceutics International Inc. (IPCI)

Категория

Выручка компании Intellipharmaceutics International Inc. (IPCI)
Выручка на Aug 2023 TTM: $904.95K
Согласно последним финансовым отчетам Intellipharmaceutics International Inc., текущая выручка компании (TTM) составляет $904.95K. В 2021 году компания получила выручку $65.73K меньше, чем выручке в 2020 году, которая составила $1.40M. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Intellipharmaceutics International Inc. с 1999 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $904.95K 1,276.80%
2022 $65.73K 0.00%
2021 $65.73K -95.31%
2020 $1.40M 0.00%
2019 $1.40M -18.17%
2018 $1.71M -68.88%
2017 $5.50M 144.97%
2016 $2.25M -45.11%
2015 $4.09M -53.32%
2014 $8.77M 474.13%
2013 $1.53M 1,326.33%
2012 $107.09K -78.66%
2011 $501.81K -65.61%
2010 $1.46M 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 0.00%
2003 0.00 0.00%
2002 0.00 -100.00%
2001 $1.00K 0.02%
2000 $999.82 -99.00%
1999 $100.06K 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
$12.62B 1,394,933.52%
US
$2.23B 246,102.54%
US
$15.74B 1,739,708.47%
AU
$6.02B 665,275.32%
NL
- -
CH